December 5-6th, 2017

San Diego, CA

The Annual Oncolytic Virotherapy Summit is dedicated to foster the next wave of genetically modified viruses that target, replicate and kill cancer cells in a clinical setting, spurred on by advanced genetic engineering techniques.

By better understanding oncolytic platforms, preclinical virotherapy models, clinical strategy and scalable manufacture of viruses, Oncolytic Virotherapy Summit is the only industry-focused gathering allowing you to capitalize on this inflection point and enhance the translation of innovative basic research into the next generation of clinically-relevant virotherapeutics.

“I am most excited about brining the oncolytic immunotherapy field together with senior representatives of big pharma/biotech in an interactive high level forum” - CEO, Replimmune

Media Partner